The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2015
Filed:
Apr. 30, 2014
Applicant:
Sympara Medical, Inc., San Francisco, CA (US);
Inventors:
Kevin Joe Ehrenreich, San Francisco, CA (US);
Randolf von Oepen, Aptos, CA (US);
Kelly Justin McCrystle, Menlo Park, CA (US);
Assignee:
Sympara Medical, Inc., San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61H 1/00 (2006.01); A61H 23/00 (2006.01); A61H 23/02 (2006.01); A61H 23/04 (2006.01);
U.S. Cl.
CPC ...
A61H 23/00 (2013.01); A61H 1/00 (2013.01); A61H 2201/5028 (2013.01); A61H 2201/0196 (2013.01); A61H 2201/1614 (2013.01); A61H 23/0236 (2013.01); A61H 23/0245 (2013.01); A61H 23/04 (2013.01); A61H 2201/0207 (2013.01); A61H 2201/1609 (2013.01); A61H 2201/165 (2013.01); A61H 2201/5007 (2013.01); A61H 2201/5015 (2013.01); A61H 2201/5035 (2013.01); A61H 2201/5038 (2013.01); A61H 2201/5041 (2013.01); A61H 2201/5043 (2013.01); A61H 2201/5058 (2013.01); A61H 2201/5084 (2013.01); A61H 2201/5092 (2013.01); A61H 2201/5097 (2013.01); A61H 2230/045 (2013.01); A61H 2230/065 (2013.01); A61H 2230/208 (2013.01); A61H 2230/305 (2013.01); A61H 2230/505 (2013.01); A61H 2230/705 (2013.01); A61H 2023/002 (2013.01);
Abstract
Devices, systems and methods are described which control blood pressure and nervous system activity by stimulating baroreceptors. By selectively and controllably activating baroreceptors and/or nerves, the present invention reduces blood pressure and alters the sympathetic nervous system; thereby minimizing deleterious effects on the heart, vasculature and other organs and tissues. A baroreceptor activation device or other sensory activation device is positioned near a dermal bone to provide the treatment.